Samir S Shah1,2,3, Rajendu Srivastava4,5, Susan Wu6,7, Jeffrey D Colvin8, Derek J Williams9,10, Shawn J Rangel11,12, Waheeda Samady13,14, Suchitra Rao15,16, Christopher Miller4, Cynthia Cross17,18, Caitlin Clohessy19, Matthew Hall20, Russell Localio21, Matthew Bryan21, Gong Wu22, Ron Keren22,23. 1. Divisions of Hospital Medicine and samir.shah@cchmc.org. 2. Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 3. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. 4. Division of Inpatient Medicine, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah. 5. Institute for Healthcare Delivery Research and Primary Children's Hospital, Intermountain Healthcare, Salt Lake City, Utah. 6. Division of Hospital Medicine, Children's Hospital of Los Angeles, Los Angeles, California. 7. Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, California. 8. Division of General Academic Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri. 9. Division of Hospital Medicine, Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee. 10. Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee. 11. Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 12. Harvard Medical School, Boston, Massachusetts. 13. Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 14. Northwestern Feinberg School of Medicine, Chicago, Illinois. 15. Division of Infectious Diseases and of Hospital Medicine, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado. 16. Department of Pediatrics, Children's Hospital Colorado, Aurora, Colorado. 17. Division of Pediatric Hospital Medicine, LeBonheur Children's Hospital, Memphis, Tennessee. 18. Department of Pediatrics, University of Tennessee College of Medicine, Memphis, Tennessee. 19. Divisions of Hospital Medicine and. 20. Children's Hospital Association, Overland Park, Kansas. 21. Department of Biostatistics and Epidemiology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 22. Division of General Pediatrics, Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and. 23. Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Abstract
BACKGROUND AND OBJECTIVES: Postdischarge treatment of complicated pneumonia includes antibiotics administered intravenously via a peripherally inserted central venous catheter (PICC) or orally. Antibiotics administered via PICC, although effective, may result in serious complications. We compared the effectiveness and treatment-related complications of postdischarge antibiotics delivered by these 2 routes. METHODS: This multicenter retrospective cohort study included children ≥2 months and <18 years discharged with complicated pneumonia between 2009 and 2012. The main exposure was the route of postdischarge antibiotic administration, classified as PICC or oral. The primary outcome was treatment failure. Secondary outcomes included PICC complications, adverse drug reactions, other related revisits, and a composite of all 4 outcomes, termed "all related revisits." RESULTS: Among 2123 children, 281 (13.2%) received antibiotics via PICC. Treatment failure rates were 3.2% among PICC and 2.6% among oral antibiotic recipients and were not significantly different between the groups in across-hospital-matched analysis (matched odds ratio [OR], 1.26; 95% confidence interval [CI], 0.54 to 2.94). PICC complications occurred in 7.1%. Adverse drug reactions occurred in 0.6% of children; PICC antibiotic recipients had greater odds of adverse drug reaction in across hospital matched analysis (matched OR, 19.1; 95% CI, 4.2 to 87.3). The high rate of PICC complications and differences in adverse drug reactions contributed to higher odds of the composite outcome of all related revisits among PICC antibiotic recipients (matched OR, 4.71; 95% CI, 2.97 to 7.46). CONCLUSIONS: Treatment failure rates between PICC and oral antibiotics did not differ. Children with complicated pneumonia should preferentially receive oral antibiotics at discharge when effective oral options are available.
BACKGROUND AND OBJECTIVES: Postdischarge treatment of complicated pneumonia includes antibiotics administered intravenously via a peripherally inserted central venous catheter (PICC) or orally. Antibiotics administered via PICC, although effective, may result in serious complications. We compared the effectiveness and treatment-related complications of postdischarge antibiotics delivered by these 2 routes. METHODS: This multicenter retrospective cohort study included children ≥2 months and <18 years discharged with complicated pneumonia between 2009 and 2012. The main exposure was the route of postdischarge antibiotic administration, classified as PICC or oral. The primary outcome was treatment failure. Secondary outcomes included PICC complications, adverse drug reactions, other related revisits, and a composite of all 4 outcomes, termed "all related revisits." RESULTS: Among 2123 children, 281 (13.2%) received antibiotics via PICC. Treatment failure rates were 3.2% among PICC and 2.6% among oral antibiotic recipients and were not significantly different between the groups in across-hospital-matched analysis (matched odds ratio [OR], 1.26; 95% confidence interval [CI], 0.54 to 2.94). PICC complications occurred in 7.1%. Adverse drug reactions occurred in 0.6% of children; PICC antibiotic recipients had greater odds of adverse drug reaction in across hospital matched analysis (matched OR, 19.1; 95% CI, 4.2 to 87.3). The high rate of PICC complications and differences in adverse drug reactions contributed to higher odds of the composite outcome of all related revisits among PICC antibiotic recipients (matched OR, 4.71; 95% CI, 2.97 to 7.46). CONCLUSIONS: Treatment failure rates between PICC and oral antibiotics did not differ. Children with complicated pneumonia should preferentially receive oral antibiotics at discharge when effective oral options are available.
Authors: Nathan M Krah; Tyler Bardsley; Richard Nelson; Lawanda Esquibel; Mark Crosby; Carrie L Byington; Andrew T Pavia; Adam L Hersh Journal: Hosp Pediatr Date: 2019-04
Authors: Mark I Neuman; Matthew Hall; Susan C Lipsett; Adam L Hersh; Derek J Williams; Jeffrey S Gerber; Thomas V Brogan; Anne J Blaschke; Carlos G Grijalva; Kavita Parikh; Lilliam Ambroggio; Samir S Shah Journal: Pediatrics Date: 2017-08-23 Impact factor: 7.124
Authors: Sanyukta Desai; Paul L Aronson; Veronika Shabanova; Mark I Neuman; Frances Balamuth; Christopher M Pruitt; Adrienne G DePorre; Lise E Nigrovic; Sahar N Rooholamini; Marie E Wang; Richard D Marble; Derek J Williams; Laura Sartori; Rianna C Leazer; Christine Mitchell; Samir S Shah Journal: Pediatrics Date: 2019-08-20 Impact factor: 7.124
Authors: Jonathan D Smirl; Dakota Peacock; Joel S Burma; Alexander D Wright; Kevin J Bouliane; Jill Dierijck; Michael Kennefick; Colin Wallace; Paul van Donkelaar Journal: Eur J Appl Physiol Date: 2022-02-16 Impact factor: 3.078
Authors: Jillian M Cotter; Matt Hall; Sonya Tang Girdwood; John R Stephens; Jessica L Markham; James C Gay; Samir S Shah Journal: J Hosp Med Date: 2021-02 Impact factor: 2.960
Authors: Peter J Gill; Ann Bayliss; Aubrey Sozer; Francine Buchanan; Karen Breen-Reid; Kim De Castris-Garcia; Mairead Green; Michelle Quinlan; Noel Wong; Shelley Frappier; Katherine Cowan; Carol Chan; Dana Arafeh; Mohammed Rashid Anwar; Colin Macarthur; Patricia C Parkin; Eyal Cohen; Sanjay Mahant Journal: JAMA Netw Open Date: 2022-04-01
Authors: Michael E Fenster; Adam L Hersh; Rajendu Srivastava; Ron Keren; Jacob Wilkes; Eric R Coon Journal: J Hosp Med Date: 2020-12 Impact factor: 2.899